Journal Article
I. Hallikainen, Hongisto, K., Välimäki, T., Hänninen, T., Martikainen, J., and Koivisto, A. M.,
“The Progression of Neuropsychiatric Symptoms in Alzheimer's Disease During a Five-Year Follow-Up: Kuopio ALSOVA Study.”,
J Alzheimers Dis, vol. 61, no. 4, pp. 1367-1376, 2018.
N. M. E. Scheltens, Tijms, B. M., Heymans, M. W., Rabinovici, G. D., Cohn-Sheehy, B. I., Miller, B. L., Kramer, J. H., Wolfsgruber, S., Wagner, M., Kornhuber, J., Peters, O., Scheltens, P., and van der Flier, W. M.,
“Prominent Non-Memory Deficits in Alzheimer's Disease Are Associated with Faster Disease Progression.”,
J Alzheimers Dis, 2018.
H. P Reddy, Manczak, M., Yin, X. L., Grady, M. Catherine, Mitchell, A., Tonk, S., Kuruva, C. Sekhar, Bhatti, J. Singh, Kandimalla, R., Vijayan, M., Kumar, S., Wang, R., Pradeepkiran, J. Adi, Ogunmokun, G., Thamarai, K., Quesada, K., Boles, A., and Reddy, A. P.,
“Protective Effects of Indian Spice Curcumin Against Amyloid-β in Alzheimer's Disease.”,
J Alzheimers Dis, vol. 61, no. 3, pp. 843-866, 2018.
A. F. N. Rosenberger, Hilhorst, R., Coart, E., Barrado, L. García, Naji, F., Rozemuller, A. J. M., van der Flier, W. M., Scheltens, P., Hoozemans, J. J. M., and van der Vies, S. M.,
“Protein Kinase Activity Decreases with Higher Braak Stages of Alzheimer's Disease Pathology.”,
J Alzheimers Dis, vol. 49, no. 4, pp. 927-43, 2016.
A. F. N. Rosenberger, Hilhorst, R., Coart, E., Barrado, L. García, Naji, F., Rozemuller, A. J. M., van der Flier, W. M., Scheltens, P., Hoozemans, J. J. M., and van der Vies, S. M.,
“Protein Kinase Activity Decreases with Higher Braak Stages of Alzheimer's Disease Pathology.”,
J Alzheimers Dis, vol. 49, no. 4, pp. 927-43, 2016.
M. I. Short, Fohner, A. E., Skjellegrind, H. K., Beiser, A., Gonzales, M. M., Satizabal, C. L., Austin, T. R., Longstreth, W. T., Bis, J. C., Lopez, O., Hveem, K., Selbæk, G., Larson, M. G., Yang, Q., Aparicio, H. J., McGrath, E. R., Gerszten, R. E., DeCarli, C. S., Psaty, B. M., Vasan, R. S., Zare, H., and Seshadri, S.,
“Proteome Network Analysis Identifies Potential Biomarkers for Brain Aging.”,
J Alzheimers Dis, vol. 96, no. 4, pp. 1767-1780, 2023.
S. E. O'Bryant, Zhang, F., Petersen, M., Hall, J. R., Johnson, L. A., Yaffe, K., Braskie, M., Vig, R., Toga, A. W., and Rissman, R. A.,
“Proteomic Profiles of Neurodegeneration Among Mexican Americans and Non-Hispanic Whites in the HABS-HD Study.”,
J Alzheimers Dis, vol. 86, no. 3, pp. 1243-1254, 2022.
A. Jacquin-Piques, Sacco, G., Tavassoli, N., Rouaud, O., Bejot, Y., Giroud, M., Robert, P., Vellas, B., and Bonin-Guillaume, S.,
“Psychotropic Drug Prescription in Patients with Dementia: Nursing Home Residents Versus Patients Living at Home.”,
J Alzheimers Dis, vol. 49, no. 3, pp. 671-80, 2016.
M. Maxime Lavallée, Gandini, D., Rouleau, I., Vallet, G. T., Joannette, M., Kergoat, M. - J., Busigny, T., Rossion, B., and Joubert, S.,
“A Qualitative Impairment in Face Perception in Alzheimer's Disease: Evidence from a Reduced Face Inversion Effect.”,
J Alzheimers Dis, vol. 51, no. 4, pp. 1225-36, 2016.
R. L. H. Handels, Sköldunger, A., Bieber, A., Edwards, R. Tudor, Gonçalves-Pereira, M., Hopper, L., Irving, K., Jelley, H., Kerpershoek, L., Marques, M. J., Meyer, G., Michelet, M., Portolani, E., Røsvik, J., Selbaek, G., Stephan, A., de Vugt, M., Wolfs, C., Woods, B., Zanetti, O., Verhey, F., and Wimo, A.,
“Quality of Life, Care Resource Use, and Costs of Dementia in 8 European Countries in a Cross-Sectional Cohort of the Actifcare Study.”,
J Alzheimers Dis, vol. 66, no. 3, pp. 1027-1040, 2018.
P. Liu, Reichl, J. H., Rao, E. R., McNellis, B. M., Huang, E. S., Hemmy, L. S., Forster, C. L., Kuskowski, M. A., Borchelt, D. R., Vassar, R., Ashe, K. H., and Zahs, K. R.,
“Quantitative Comparison of Dense-Core Amyloid Plaque Accumulation in Amyloid-β Protein Precursor Transgenic Mice.”,
J Alzheimers Dis, vol. 56, no. 2, pp. 743-761, 2017.
M. Ramos de Matos, Ferreira, C., Herukka, S. - K., Soininen, H., Janeiro, A., Santana, I., Baldeiras, I., Almeida, M. Rosário, Lleo, A., Dols-Icardo, O., Alcolea, D., Benussi, L., Binetti, G., Paterlini, A., Ghidoni, R., Nacmias, B., Meulenbroek, O., van Doorn, L. J. C. van Wa, H Kuiperi, B. J., Hausner, L., Waldemar, G., Simonsen, A. Hviid, Tsolaki, M., Gkatzima, O., de Oliveira, C. Resende, Verbeek, M. M., Clarimón, J., Hiltunen, M., de Mendonça, A., and Martins, M.,
“Quantitative Genetics Validates Previous Genetic Variants and Identifies Novel Genetic Players Influencing Alzheimer's Disease Cerebrospinal Fluid Biomarkers.”,
J Alzheimers Dis, vol. 66, no. 2, pp. 639-652, 2018.
M. Ramos de Matos, Ferreira, C., Herukka, S. - K., Soininen, H., Janeiro, A., Santana, I., Baldeiras, I., Almeida, M. Rosário, Lleo, A., Dols-Icardo, O., Alcolea, D., Benussi, L., Binetti, G., Paterlini, A., Ghidoni, R., Nacmias, B., Meulenbroek, O., van Doorn, L. J. C. van Wa, H Kuiperi, B. J., Hausner, L., Waldemar, G., Simonsen, A. Hviid, Tsolaki, M., Gkatzima, O., de Oliveira, C. Resende, Verbeek, M. M., Clarimón, J., Hiltunen, M., de Mendonça, A., and Martins, M.,
“Quantitative Genetics Validates Previous Genetic Variants and Identifies Novel Genetic Players Influencing Alzheimer's Disease Cerebrospinal Fluid Biomarkers.”,
J Alzheimers Dis, vol. 66, no. 2, pp. 639-652, 2018.
C. Groot, Tolboom, N., Ikonomovic, M. D., Lammertsma, A. A., Boon, B. D. C., Barkhof, F., Scheltens, P., Klunk, W. E., Rozemuller, A. J. M., Ossenkoppele, R., and van Berckel, B. N. M.,
“Quantitative PET and Histology of Brain Biopsy Reveal Lack of Selective Pittsburgh Compound-B Binding to Intracerebral Amyloidoma.”,
J Alzheimers Dis, 2018.
E. Louwersheimer, Cohn-Hokke, P. E., Pijnenburg, Y. A. L., Weiss, M. M., Sistermans, E. A., Rozemuller, A. J., Hulsman, M., van Swieten, J. C., van Duijn, C. M., Barkhof, F., Koene, T., Scheltens, P., van der Flier, W. M., and Holstege, H.,
“Rare Genetic Variant in SORL1 May Increase Penetrance of Alzheimer's Disease in a Family with Several Generations of APOE-ɛ4 Homozygosity.”,
J Alzheimers Dis, vol. 56, no. 1, pp. 63-74, 2017.
E. Louwersheimer, Cohn-Hokke, P. E., Pijnenburg, Y. A. L., Weiss, M. M., Sistermans, E. A., Rozemuller, A. J., Hulsman, M., van Swieten, J. C., van Duijn, C. M., Barkhof, F., Koene, T., Scheltens, P., van der Flier, W. M., and Holstege, H.,
“Rare Genetic Variant in SORL1 May Increase Penetrance of Alzheimer's Disease in a Family with Several Generations of APOE-ɛ4 Homozygosity.”,
J Alzheimers Dis, vol. 56, no. 1, pp. 63-74, 2017.
E. Louwersheimer, Cohn-Hokke, P. E., Pijnenburg, Y. A. L., Weiss, M. M., Sistermans, E. A., Rozemuller, A. J., Hulsman, M., van Swieten, J. C., van Duijn, C. M., Barkhof, F., Koene, T., Scheltens, P., van der Flier, W. M., and Holstege, H.,
“Rare Genetic Variant in SORL1 May Increase Penetrance of Alzheimer's Disease in a Family with Several Generations of APOE-ɛ4 Homozygosity.”,
J Alzheimers Dis, vol. 56, no. 1, pp. 63-74, 2017.
W. Wharton, Goldstein, F. C., Tansey, M. G., Brown, A. L., Tharwani, S. D., Verble, D. D., Cintron, A., and Kehoe, P. G.,
“Rationale and Design of the Mechanistic Potential of Antihypertensives in Preclinical Alzheimer's (HEART) Trial.”,
J Alzheimers Dis, vol. 61, no. 2, pp. 815-824, 2018.
A. Vojdani, Vojdani, E., Saidara, E., and Kharrazian, D.,
“Reaction of Amyloid-β Peptide Antibody with Different Infectious Agents Involved in Alzheimer's Disease.”,
J Alzheimers Dis, vol. 63, no. 2, pp. 847-860, 2018.
A. Vojdani, Vojdani, E., Saidara, E., and Kharrazian, D.,
“Reaction of Amyloid-β Peptide Antibody with Different Infectious Agents Involved in Alzheimer's Disease.”,
J Alzheimers Dis, vol. 63, no. 2, pp. 847-860, 2018.
R. García de Eulate, Goñi, I., Galiano, A., Vidorreta, M., Recio, M., Riverol, M., Zubieta, J. L., and Fernández-Seara, M. A.,
“Reduced Cerebral Blood Flow in Mild Cognitive Impairment Assessed Using Phase-Contrast MRI.”,
J Alzheimers Dis, vol. 58, no. 2, pp. 585-595, 2017.
B. Soukupova Urbanova, Schwabova, J. Paulasova, Magerova, H., Jansky, P., Marková, H., Vyhnálek, M., Laczó, J., Hort, J., and Tomek, A.,
“Reduced Cerebrovascular Reserve Capacity as a Biomarker of Microangiopathy in Alzheimer's Disease and Mild Cognitive Impairment.”,
J Alzheimers Dis, vol. 63, no. 2, pp. 465-477, 2018.
L. D. Estrada, Chamorro, D., Yañez, M. José, Gonzalez, M., Leal, N., von Bernhardi, R., Dulcey, A. E., Marugan, J., Ferrer, M., Soto, C., Zanlungo, S., Inestrosa, N. C., and Alvarez, A. R.,
“Reduction of Blood Amyloid-β Oligomers in Alzheimer's Disease Transgenic Mice by c-Abl Kinase Inhibition.”,
J Alzheimers Dis, vol. 54, no. 3, pp. 1193-1205, 2016.
A. Alghamdi, Vallortigara, J., Howlett, D. R., Broadstock, M., Hortobágyi, T., Ballard, C., Thomas, A. J., O'Brien, J. T., Aarsland, D., Attems, J., Francis, P. T., and Whitfield, D. R.,
“Reduction of RPT6/S8 (a Proteasome Component) and Proteasome Activity in the Cortex is associated with Cognitive Impairment in Lewy Body Dementia.”,
J Alzheimers Dis, vol. 57, no. 2, pp. 373-386, 2017.
A. Vipin, Foo, H. Jing Ling, Lim, J. Kai Wei, Chander, R. Jude, Yong, T. Ting, Ng, A. Su Lyn, Hameed, S., Ting, S. Kang Seng, Zhou, J., and Kandiah, N.,
“Regional White Matter Hyperintensity Influences Grey Matter Atrophy in Mild Cognitive Impairment.”,
J Alzheimers Dis, vol. 66, no. 2, pp. 533-549, 2018.
] Year 